Jacob I. Contreras
Affiliations: | 2012-2017 | University of Nebraska Medical Center, Omaha, NE, United States |
Google:
"Jacob Contreras"Mean distance: (not calculated yet)
Parents
Sign in to add mentorAmarnath (Amar) Natarajan | grad student | 2012-2017 | University of Nebraska Medical Center |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Sagar S, Singh S, Mallareddy JR, et al. (2021) Structure activity relationship (SAR) study identifies a quinoxaline urea analog that modulates IKKβ phosphorylation for pancreatic cancer therapy. European Journal of Medicinal Chemistry. 222: 113579 |
Robb CM, Kour S, Contreras JI, et al. (2020) Correction: Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy. Oncotarget. 11: 2462-2463 |
Rana S, Kour S, Sonawane YA, et al. (2020) Symbiotic Prodrugs (SymProDs) Dual Targeting of NFkappaB and CDK. Chemical Biology & Drug Design |
Kour S, Rana S, Contreras JI, et al. (2019) CDK5 Inhibitor Downregulates Mcl-1 and Sensitizes Pancreatic Cancer Cell Lines to Navitoclax. Molecular Pharmacology. 96: 419-429 |
Contreras JI, Robb CM, King HM, et al. (2018) Chemical Genetic Screens Identify Kinase Inhibitor Combinations that Target Anti-Apoptotic Proteins for Cancer Therapy. Acs Chemical Biology |
Robb CM, Kour S, Contreras JI, et al. (2018) Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy. Oncotarget. 9: 5216-5232 |
Robb CM, Contreras JI, Kour S, et al. (2017) Chemically induced degradation of CDK9 by a proteolysis targeting chimera (PROTAC). Chemical Communications (Cambridge, England) |
Yefidoff-Freedman R, Fan J, Yan L, et al. (2017) Development of 1-((1,4-trans)-4-aryloxycyclohexyl)-3-arylurea Activators of the Heme Regulated Inhibitor as Selective Activators of Eucaryotic Translation Initiation Factor 2 Alpha (eIF2α) Phosphorylation Arm of the Integrated Endoplasmic Reticulum Stress Response. Journal of Medicinal Chemistry |
Arnst JL, Hein AL, Taylor MA, et al. (2017) Discovery and characterization of small molecule Rac1 inhibitors. Oncotarget |
Sonawane YA, Taylor MA, Napoleon JV, et al. (2016) Cyclin dependent kinase 9 inhibitors for cancer therapy. Journal of Medicinal Chemistry |